Becker's Healthcare March 1, 2023
Artificial intelligence-powered precision medicine company Tempus is partnering with pharmaceutical giant Pfizer on a project aiming to advance the use of AI and machine learning capabilities in oncology therapeutic discovery.
Through the partnership, Tempus will grant Pfizer access to its data library, diagnostic offerings and clinical trial matching program, according to a Feb. 28 Tempus news release.
...